Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-AzaFol PET Imaging in Folate Receptor Positive Ovarian and Lung Cancer
NCT03242993Phase 1Completed
- Sponsor
- Lausanne University Hospital
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]-AzaFol in ovarian cancer and non-small cell lung cancer (NSCLC), sponsored by Lausanne University Hospital. Primary endpoint: Standardized Uptake Value at day 0. Started Apr 2017; status: completed.
02
Drugs
[18F]-AzaFol
03
Conditions
ovarian cancernon-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03242993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242993.